Carregant...
Diagnosis and Management of Anabolic Androgenic Steroid Use
CONTEXT: The lifetime prevalence of anabolic androgenic steroid (AAS) use is estimated at 1% to 5% worldwide. AAS use occurs primarily male elite athletes and men who want a muscular appearance. The evidence for effective, safe management of AAS cessation and withdrawal is weak. DESIGN: Key studies...
Guardat en:
| Publicat a: | J Clin Endocrinol Metab |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517163/ https://ncbi.nlm.nih.gov/pubmed/30753550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01882 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|